Title |
Interferon-beta responders and non-responders. A biological approach
|
---|---|
Published in |
Neurological Sciences, August 2008
|
DOI | 10.1007/s10072-008-0941-2 |
Pubmed ID | |
Authors |
Antonio Bertolotto, Francesca Gilli |
Abstract |
The therapeutic benefits of interferon-beta are limited, as some patients with multiple sclerosis (MS) do not respond to therapy. Based on their biological characteristics, non-responsive patients can be divided into three subgroups: genetic, pharmacological and pathogenetic non-responders. In order to tailor the best treatment in both newly diagnosed MS patients and those already receiving treatment, the neurologist must carefully consider the risk of treating non-responders. |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 5% |
Turkey | 1 | 5% |
Unknown | 20 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 5 | 23% |
Student > Ph. D. Student | 4 | 18% |
Professor > Associate Professor | 3 | 14% |
Student > Bachelor | 2 | 9% |
Student > Postgraduate | 2 | 9% |
Other | 4 | 18% |
Unknown | 2 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 4 | 18% |
Medicine and Dentistry | 4 | 18% |
Neuroscience | 3 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 9% |
Computer Science | 2 | 9% |
Other | 3 | 14% |
Unknown | 4 | 18% |